Alnylam Pharmaceuticals | ALNY - 资产

股票价格

296.13

每天变化

-5.98 -1.98%

每月一次

-6.31%

每年

12.49%

Q2 预测

299.00

金融业

USD

USD 4.97B

现金及等价物

USD 1.66B

USD 267.72M

USD 4.05B

USD 1.47B

USD 1.31B

USD 29.4M

USD 145.22M

2.23K

EPS每股收益

USD 1.25

股本和储备

USD 789.18M

USD 829.31M

债务利息支出

USD 129.34M

USD 28.68M

USD 2.48B

USD 39.15B

USD 186.42M

USD 965.32M

USD 29.4M

普通股股本

USD 132.38M

170.7

USD 161.14M

USD 1.1B

销售和管理费用

USD 285.06M

USD 82.72M

贸易债权人

USD 115.72M

应收帐款人

USD 777.57M

	资产	更改		日
Acadia Pharmaceuticals	USD 1.56B		233.42M	2025-12
Agios Pharmaceuticals	USD 1.18B		112.24M	2026-03
Alnylam Pharmaceuticals	USD 4.97B		114.67M	2025-12
Amgen	USD 90.59B		445M	2025-12
Arrowhead Research	USD 1.6B		218.89M	2025-12
BioCryst Pharmaceuticals	USD 514.16M		67.73M	2025-12
BioMarin Pharmaceutical	USD 7.59B		20.85M	2025-12
Incyte	USD 7.34B		381.14M	2026-03
Ionis Pharmaceuticals	USD 3.45B		74M	2026-03
Moderna	USD 12.34B		203M	2025-12
Neurocrine Biosciences	USD 4.63B		365.8M	2025-12
Novartis	USD 110.95B		3.66B	2025-12
PTC Therapeutics	USD 2.9B		255.07M	2025-12
Regeneron Pharmaceuticals	USD 40.87B		310.1M	2026-03
Sangamo BioSciences	USD 97.56M		11.39M	2025-06
Sanofi	EUR 126.81B		25.48B	2025-12
Sarepta Therapeutics	USD 3.35B		143.73M	2025-12
Takeda	JPY 15.41T		938.47B	2025-12
Tectonic Therapeutic	USD 261.04M		15.96M	2025-12
Ultragenyx Pharmaceutical	USD 1.53B		341.56M	2025-12
Vertex Pharmaceuticals	USD 25.64B		780.7M	2025-12
Xencor	USD 875.5M		6.68M	2025-12